- Home
- CSGS vs DAWN Comparison
CSGS vs DAWN Comparison
Compare CSGS & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSGS
- DAWN
- Stock Information
- Founded
- CSGS 1994
- DAWN 2018
- Country
- CSGS United States
- DAWN United States
- Employees
- CSGS N/A
- DAWN N/A
- Industry
- CSGS EDP Services
- DAWN Biotechnology: Pharmaceutical Preparations
- Sector
- CSGS Technology
- DAWN Health Care
- Exchange
- CSGS Nasdaq
- DAWN Nasdaq
- Market Cap
- CSGS 1.6B
- DAWN 1.6B
- IPO Year
- CSGS 1996
- DAWN 2021
- Fundamental
- Price
- CSGS $54.48
- DAWN $13.31
- Analyst Decision
- CSGS Strong Buy
- DAWN Strong Buy
- Analyst Count
- CSGS 5
- DAWN 7
- Target Price
- CSGS $61.60
- DAWN $36.17
- AVG Volume (30 Days)
- CSGS 252.0K
- DAWN 1.3M
- Earning Date
- CSGS 11-06-2024
- DAWN 10-30-2024
- Dividend Yield
- CSGS 2.20%
- DAWN N/A
- EPS Growth
- CSGS N/A
- DAWN N/A
- EPS
- CSGS 2.27
- DAWN N/A
- Revenue
- CSGS $1,177,920,000.00
- DAWN $101,953,000.00
- Revenue This Year
- CSGS N/A
- DAWN N/A
- Revenue Next Year
- CSGS $3.97
- DAWN $44.21
- P/E Ratio
- CSGS $23.97
- DAWN N/A
- Revenue Growth
- CSGS 1.39
- DAWN N/A
- 52 Week Low
- CSGS $39.56
- DAWN $11.30
- 52 Week High
- CSGS $57.16
- DAWN $18.07
- Technical
- Relative Strength Index (RSI)
- CSGS 67.66
- DAWN 35.44
- Support Level
- CSGS $55.22
- DAWN $14.30
- Resistance Level
- CSGS $56.70
- DAWN $15.92
- Average True Range (ATR)
- CSGS 1.65
- DAWN 0.90
- MACD
- CSGS 0.56
- DAWN -0.17
- Stochastic Oscillator
- CSGS 75.61
- DAWN 0.29
About CSGS CSG Systems International Inc.
CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from Americas (principally the U.S.).
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.